Anticancer drug development: moving away from the old habits
Curr Opin Oncol
.
2014 May;26(3):334-9.
doi: 10.1097/CCO.0000000000000076.
Authors
Felipe Ades
1
,
Dimitrios Zardavas
,
Philippe Aftimos
,
Ahmad Awada
Affiliation
1
aMedical Oncology Clinic bBreast International Group Headquarters (BIG-aisbl), Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
PMID:
24614094
DOI:
10.1097/CCO.0000000000000076
No abstract available
Publication types
Editorial
MeSH terms
Antineoplastic Agents / therapeutic use*
Clinical Trials as Topic
Drug Discovery / methods
Drug Discovery / trends*
Humans
Neoplasms / drug therapy*
Research Design / trends*
Substances
Antineoplastic Agents